# Amniotic Mesenchymal Stromal/Stem Cell–Derived Extracellular Vesicles for Equine Chronic Degenerative Endometritis Treatment

**Authors:** Giulia Gaspari, Federico Funghi, Carlo Cantile, Francesco Camillo, Duccio Panzani, Saverio Maltinti, Diana Fanelli, Rebecca Moroni, Fausto Cremonesi, Paola Gagni, Anna Lange‐Consiglio

PMC · DOI: 10.1002/vms3.70685 · 2026-02-05

## TL;DR

This study explores using amniotic cell-derived extracellular vesicles to improve fertility in mares with chronic endometritis by restoring maternal-fetal communication.

## Contribution

The novel contribution is the use of amniotic mesenchymal stromal cell-derived extracellular vesicles to treat equine chronic degenerative endometritis.

## Key findings

- Intrauterine administration of AMC-EVs improved pregnancy outcomes in mares with chronic endometritis.
- AMC-EVs likely restored maternal-fetal communication without regenerating endometrial tissue.
- One treatment cycle appeared sufficient for achieving pregnancy success.

## Abstract

Equine chronic degenerative endometritis (CDE) is a progressive process characterized by endometrial fibrosis that could be responsible for alterations of uterine environment and foetal–maternal communication.

The aim of this study was to try to restore this communication by intrauterine administrations of amniotic cell–derived extracellular vesicles (AMC‐EVs) in a case series.

Twelve mares were selected on the basis of their reproductive history of early embryonic loss or abortion and clinical suspicion of CDE subsequently verified with histopathological examination of endometrial biopsies.

Gynaecological and ultrasound examinations and histopathological examination of endometrial biopsies were performed. Mares were divided into two groups: Seven mares in Group 1 received a single treatment cycle (corresponding to two intrauterine AMC‐EV administrations), whereas five mares of Group 2 received two treatment cycles (corresponding to four intrauterine AMC‐EV administrations). Each administration was of 20 billion AMC‐EVs diluted in 50 mL of sterile saline solution.

Eleven mares were able to establish pregnancy after the treatment with AMC‐EVs without significant difference in pregnancy outcomes between one or two treatment cycles (six out of seven mares of Group 1 and all mares of Group 2 were pregnant), suggesting that one cycle may be sufficient. The histological condition of their endometrium did not show any improvement in Kenney–Doig classification, meaning AMC‐EVs did not exert regenerative activity but probably contributed to re‐establishing a functional paracrine interaction between embryo and maternal tissues.

This study has the limitation of the small number of animals enrolled and the lack of a control group. However, considering the large number of past artificial insemination attempts for each animal enrolled in this study, each mare could be considered self‐control.

It would seem possible that AMC‐EVs supported and enhanced foetal–maternal communication that was compromised by CDE.

Equine endometrium can develop progressive fibrotic and functional alterations, probably correlated with age and inflammatory insults that alter uterine microenvironment, creating hostile conditions for embryo implantation. Named chronic degenerative endometritis, this condition leads to reduced fertility in older mares. Extracellular vesicles secreted by amniotic mesenchymal stromal/stem cells carry molecules with therapeutic and regenerative properties. Their intrauterine administration in 12 mares, with several previous negative insemination attempts, led to an improvement in fertility, probably driving a significant restoration of maternal–foetal talk.

## Linked entities

- **Species:** Equus caballus (taxon 9796)

## Full-text entities

- **Genes:** CD63 [NCBI Gene 100051450], TSG101 [NCBI Gene 100057099], epidermal growth factor [NCBI Gene 100034179], IL-10 [NCBI Gene 100034187], CD81 [NCBI Gene 100060480]
- **Diseases:** necrotically (MESH:D009336), maternal pregnancy-associated disorders (MESH:D011254), CDE (MESH:D004716), AMC-EV (MESH:C535509), tendon lesions (MESH:D052256), endometrial inflammation (MESH:D007249), infertility (MESH:D007246), pathologies (MESH:D005598), embryonic loss (MESH:D020964), oedema (MESH:C536897), miscarriage (MESH:D000022), abortion (MESH:D000026), Fibrosis (MESH:D005355), AI (MESH:D060437), AMC (MESH:C563086), infections (MESH:D007239), mastitis (MESH:D008413), implantation failure (MESH:D051437), Endometrial diseases (MESH:D014591)
- **Chemicals:** haematoxylin (MESH:D006416), CO2 (MESH:D002245), water (MESH:D014867), NaCl (MESH:D012965), Tween 20 (MESH:D011136), carbon (MESH:D002244), uranyl acetate (MESH:C005460), copper (MESH:D003300), Laemmli buffer (MESH:C088816), eosin (MESH:D004801), TBS-T (MESH:C027647), AMC (-), SDS (MESH:D012967), formalin (MESH:D005557), glutaraldehyde (MESH:D005976), iodine povidone (MESH:D011206), lipid (MESH:D008055), prostaglandins (MESH:D011453)
- **Species:** Homo sapiens (human, species) [taxon 9606], Equus caballus (domestic horse, species) [taxon 9796], Bos taurus (bovine, species) [taxon 9913], Mus musculus (house mouse, species) [taxon 10090]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12874493/full.md

---
Source: https://tomesphere.com/paper/PMC12874493